What are the differences between an eFlow, Trio, and the Altera?
In 2004, the eFlow® SCF was FDA approved as “a handheld device to be used by patients for whom physicians have prescribed medication for nebulization.” On March3, 2009, SourceCF Inc., a subsidiary of Eurand Pharmaceuticals, Inc., rebranded the eFlow under the brand name TRIO™ Electronic Nebulizer. According to SourceCF, the change to the name TRIO was intended to differentiate the current device from other devices using eFlow technology that will be limited to use with a single medication.One such device is the Altera™ Nebulizer System. This device uses eFlow technology to deliver Cayston™. Cayston is only approved for use with the Altera Nebulizer System, which has been optimized specifically for Cayston.
